ProKyma Gets $783K for CTC Detection Technology Development | GenomeWeb

NEW YORK (GenomeWeb News) – UK firm ProKyma today announced a £482,000 ($783,211) grant from the National Institute for Health Research to further develop its technology to detect circulating tumor cells.

The funding will be used by the spinout of the Defence Science and Technology Laboratory — a center of scientific excellence for the Ministry of Defence — to use its KymaSep technology to find a patient's specific cancer mutation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.